Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.65 |
| ▸ | HTT | P42858 | 4/20 | 0.58 |
| ▸ | RAB9A | P51151 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | NR2F2 | P24468 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | NAMPT | P43490 | 5/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | GALR3 | O60755 | 1/20 | 0.52 |
| ▸ | SLC12A2 | P55011 | 1/20 | 0.49 |
| ▸ | SLC12A5 | Q9H2X9 | 1/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27083363 | 0.83 | SMN1; SMN2 (0.82) | LMNASMN1; SMN2HTTRAB9ANR2F2 | |
| SCHEMBL30864994 | 0.82 | LMNA (0.58) | LMNASMN1; SMN2HTTRAB9AKMT2A | |
| SCHEMBL27083343 | 0.82 | LMNA (0.58) | LMNASMN1; SMN2HTTRAB9AKMT2A | |
| SCHEMBL4402015 | 0.82 | SMN1; SMN2 (0.66) | LMNASMN1; SMN2HTTRAB9AKMT2A | |
| SCHEMBL27083360 | 0.81 | SMN1; SMN2 (0.73) | LMNASMN1; SMN2HTTRAB9ANR2F2 | |
| SCHEMBL4662893 | 0.80 | SMN1; SMN2 (1.00) | LMNASMN1; SMN2HTTRAB9ANR2F2 | |
| SCHEMBL27083331 | 0.77 | LMNA (0.58) | LMNASMN1; SMN2HTTRAB9AKMT2A | |
| SCHEMBL30865004 | 0.76 | SMN1; SMN2 (0.66) | LMNASMN1; SMN2HTTRAB9ANR2F2 | |
| SCHEMBL27083380 | 0.76 | SMN1; SMN2 (0.66) | LMNASMN1; SMN2HTTRAB9ANR2F2 | |
| SCHEMBL27083341 | 0.76 | SMN1; SMN2 (0.64) | LMNASMN1; SMN2HTTRAB9ANR2F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1860941-B1 | BIPHENYL-N-(4-PYRIDYL) METHYLSUFONAMIDES | BASF SE (DE) | 2008-11-12 | — | — | EP | disclosed |
| US-20080161187-A1 | Controlling phytopathogenic harmful fungi and harmful arthropodes; combating arthropodal pestsprotecting crops, seeds and non-living materials from infestation by arthropodal pests; insecticides, pesticides, fungicides; miticides; agriculture; veterinary medicine | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-03 | — | — | US | disclosed |
| EP-1860941-A1 | BIPHENYL-N-(4-PYRIDYL) METHYLSUFONAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-05 | — | — | EP | disclosed |
| WO-2006097489-A1 | BIPHENYL-N-(4-PYRIDYL) METHYLSUFONAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161187-A1 | Controlling phytopathogenic harmful fungi and harmful arthropodes; combating arthropodal pestsprotecting crops, seeds and non-living materials from infestation by arthropodal pests; insecticides, pesticides, fungicides; miticides; agriculture; veterinary medicine | PTPN21, PTPN1, PTPN14 | LMNA 4054/4885SMN1; SMN2 2697/4885HTT 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.